1. Switzerland Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018
Report Details:
Published:September 2012
No. of Pages: 73
Price: Single User License – US$2500
Switzerland Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2018
Summary
Global Markets Direct’s new report, “Switzerland Diabetes Care Devices Investment Opportunities,
Analysis and Forecasts to 2018” provides key market data on the Switzerland Diabetes Care
Devices market. The report provides value (USD million), volume (units) and average price (USD)
data for each segment and sub-segment within two market categories – Glucose Monitoring and
Insulin Delivery. The report also provides company shares and distribution shares data for each of
the aforementioned market categories. The report is supplemented with global corporate-level
profiles of the key market participants with information on company financials and pipeline
products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by Global Markets Direct’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Switzerland Diabetes Care
Devices market.
- Key players covered include F. Hoffmann-La Roche Ltd., Eli Lilly and Company , Sanofi , Novo
Nordisk A/S , LifeScan, Inc., Medtronic, Inc.and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Switzerland Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/195377-switzerland-diabetes-care-devices-investment-opportunities-
analysis-and-forecasts-to-2018.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What is This Report About? 7
3 Diabetes Care Devices In Switzerland 8
3.1 Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, 2004-2018 8
3.2 Diabetes Care Devices, Switzerland, Company Share (2010-2011) 14
4 Glucose Monitoring In Switzerland 16
4.1 Glucose Monitoring Overall Revenue, (2004-2018) 16
4.1.1 Blood Glucose Meters, Revenue (2004-2018) 20
4.2 Glucose Monitoring Overall Volume (2004-2018) 24
4.2.1 Blood Glucose Meters, Volume (2004-2018) 28
4.3 Glucose Monitoring Average Price (2004-2018) 31
4.4 Glucose Monitoring Distribution Share (2010-2011) 32
4.5 Glucose Monitoring, Switzerland, Company Share (2010-2011) 33
5 Insulin Delivery In Switzerland 35
5.1 Insulin Delivery Overall Revenue, (2004-2018) 35
5.1.1 Insulin Pens, Revenue (2004-2018) 39
5.1.2 Insulin Pumps, Revenue (2004-2018) 43
5.2 Insulin Delivery Overall Volume (2004-2018) 47
5.2.1 Insulin Pens, Volume (2004-2018) 51
5.2.2 Insulin Pumps, Volume (2004-2018) 55
5.3 Insulin Delivery Average Price (2004-2018) 57
5.4 Insulin Delivery Distribution Share (2010-2011) 58

3. 5.5 Insulin Delivery, Switzerland, Company Share (2010-2011) 59
6 Overview of Key Companies in Switzerland Diabetes Care Devices Market 61
6.1 F. Hoffmann-La Roche Ltd. 61
6.1.1 Company Overview 61
6.2 Eli Lilly and Company 61
6.2.1 Company Overview 61
6.3 Sanofi 62
6.3.1 Company Overview 62
6.4 Novo Nordisk A/S 62
6.4.1 Company Overview 62
6.5 LifeScan, Inc. 62
6.5.1 Company Overview 62
6.6 Medtronic, Inc. 63
6.6.1 Company Overview 63
6.7 Bayer HealthCare AG 63
6.7.1 Company Overview 63
6.8 Abbott Laboratories 64
6.8.1 Company Overview 64
6.9 Animas Corporation 64
6.9.1 Company Overview 64
6.10 Becton, Dickinson and Company 65
6.10.1 Company Overview 65
6.11 Ypsomed Holding AG 65
6.11.1 Company Overview 65
6.12 Terumo Corporation 66
6.12.1 Company Overview 66
6.13 Nipro Corporation 66
6.13.1 Company Overview 66
7 Appendix 67
7.1 Global Markets Direct Research Methodology 67
7.2 Definitions of Markets Covered in the Report 68
7.2.1 Diabetes Care Devices 68
7.3 Secondary Research 71
7.4 Primary Research 71
7.5 Models 72
7.6 Forecasts 72
7.7 Expert Panel Validation 72
7.8 Currency Conversion 73
7.9 Contact Us 73
7.10 Disclaimer 73
1.1 List of Tables

4. Table 1: Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, 2004-2018 9
Table 2: Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, Historic,
2004-2011 11
Table 3: Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 13
Table 4: Diabetes Care Devices, Switzerland, Company Share by Revenue ($m), USD Constant,
2010-2011 15
Table 5: Glucose Monitoring, Switzerland, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 17
Table 6: Glucose Monitoring, Switzerland, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 19
Table 7: Blood Glucose Meters, Switzerland, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 21
Table 8: Blood Glucose Meters, Switzerland, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 23
Table 9: Glucose Monitoring, Switzerland, Volume (Units) by Segment, Historic, 2004-2011 25
Table 10: Glucose Monitoring, Switzerland, Volume (Units) by Segment, Forecast, 2011-2018 27
Table 11: Blood Glucose Meters, Switzerland, Volume (Units) by Sub-Segment, Historic, 2004-
2011 28
Table 12: Blood Glucose Meters, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 30
Table 13: Glucose Monitoring, Switzerland, Average Price ($), Historic, 2004-2011 31
Table 14: Glucose Monitoring, Switzerland, Average Price ($), Forecast, 2011-2018 31
Table 15: Glucose Monitoring, Switzerland, Distribution Share by Revenue ($m), USD Constant,
2010-2011 32
Table 16: Glucose Monitoring, Switzerland, Company Share by Revenue ($m), USD Constant,
2010-2011 34
Table 17: Insulin Delivery, Switzerland, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 36
Table 18: Insulin Delivery, Switzerland, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 38
Table 19: Insulin Pens, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 40
Table 20: Insulin Pens, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 42
Table 21: Insulin Pumps, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 44
Table 22: Insulin Pumps, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 46
Table 23: Insulin Delivery, Switzerland, Volume (Units) by Segment, Historic, 2004-2011 48
Table 24: Insulin Delivery, Switzerland, Volume (Units) by Segment, Forecast, 2011-2018 50
Table 25: Insulin Pens, Switzerland, Volume (Units) by Sub-Segment, Historic, 2004-2011 52

5. Table 26: Insulin Pens, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 54
Table 27: Insulin Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic, 2004-2011 55
Table 28: Insulin Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 56
Table 29: Insulin Delivery, Switzerland, Average Price ($), Historic, 2004-2011 57
Table 30: Insulin Delivery, Switzerland, Average Price ($), Forecast, 2011-2018 57
Table 31: Insulin Delivery, Switzerland, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 58
Table 32: Insulin Delivery, Switzerland, Company Share by Revenue ($m), USD Constant, 2010-
2011 60
1.2 List of Figures
Figure 1: Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, 2004-2018
8
Figure 2: Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, Historic,
2004-2011 10
Figure 3: Diabetes Care Devices, Switzerland, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 12
Figure 4: Diabetes Care Devices, Switzerland, Company Share (%), 2011 14
Figure 5: Glucose Monitoring, Switzerland, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 16
Figure 6: Glucose Monitoring, Switzerland, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 18
Figure 7: Blood Glucose Meters, Switzerland, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 20
Figure 8: Blood Glucose Meters, Switzerland, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 22
Figure 9: Glucose Monitoring, Switzerland, Volume (Units) by Segment, Historic, 2004-2011 24
Figure 10: Glucose Monitoring, Switzerland, Volume (Units) by Segment, Forecast, 2011-2018 26
Figure 11: Blood Glucose Meters, Switzerland, Volume (Units) by Sub-Segment, Historic, 2004-
2011 28
Figure 12: Blood Glucose Meters, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 29
Figure 13: Glucose Monitoring, Switzerland, Company Share (%), 2011 33
Figure 14: Insulin Delivery, Switzerland, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 35
Figure 15: Insulin Delivery, Switzerland, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 37
Figure 16: Insulin Pens, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 39
Figure 17: Insulin Pens, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 41
Figure 18: Insulin Pumps, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Historic,

6. 2004-2011 43
Figure 19: Insulin Pumps, Switzerland, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 45
Figure 20: Insulin Delivery, Switzerland, Volume (Units) by Segment, Historic, 2004-2011 47
Figure 21: Insulin Delivery, Switzerland, Volume (Units) by Segment, Forecast, 2011-2018 49
Figure 22: Insulin Pens, Switzerland, Volume (Units) by Sub-Segment, Historic, 2004-2011 51
Figure 23: Insulin Pens, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 53
Figure 24: Insulin Pumps, Switzerland, Volume (Units) by Sub-Segment, Historic, 2004-2011 55
Figure 25: Insulin Pumps, Switzerland, Volume (Units) by Sub-Segment, Forecast, 2011-2018 56
Figure 26: Insulin Delivery, Switzerland, Company Share (%), 2011 59
Figure 27: Global Markets Direct Methodology 67
Contact: sales@reportsandreports.com for more information.